IHL-42X Performs in Phase 2 RePOSA Study, ATH434 Eyes Phase 3 Multiple System Atrophy Trial, 4-Year Data on Lecanemab Unveiled
Published: | Updated:
Neurology News Network. for the week ending August 2, 2025. [WATCH TIME: 4 minutes]
NeurologyLive® Staff
Advertisement
Articles by NeurologyLive® Staff
Here's some of what is coming soon to NeurologyLive® this week.
Gefurulimab Positive Phase 3 Data Released, PoNS Device Eyes Stroke Indication, AD109 Performs in Phase 3 LunAIRo Trial
Published: | Updated:
Neurology News Network. for the week ending July 26, 2025. [WATCH TIME: 4 minutes]
Here's some of what is coming soon to NeurologyLive® this week.
Sleep Agent Oveporexton Meets End Points in Phase 3 Studies, XPro Shows Mixed Phase 2 Data, Ultraprocessed Food Consumption Linked to Parkinson's Features
Published: | Updated:
Neurology News Network. for the week ending July 19, 2025. [WATCH TIME: 4 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 18, 2025.
Here's some of what is coming soon to NeurologyLive® this week.
FDA Approves Updated Donanemab Labeling, BLA Accepted for Tividenofusp Alfa, Nipocalimab Outperforms FcRn Blockers
Published: | Updated:
Neurology News Network. for the week ending July 12, 2025. [WATCH TIME: 4 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 11, 2025.
Here's some of what is coming soon to NeurologyLive® this week.
Salanersen Shows Promise in Phase 1, MESA Open-Label Data Released, Fenfluramine Meets End Points in Phase 3 GEMZ Trial
Published: | Updated:
Neurology News Network. for the week ending July 5, 2025. [WATCH TIME: 4 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 4, 2025.
Here's some of what is coming soon to NeurologyLive® this week.
Eptinezumab Improves Medication Overuse Headache, Submission for GTx-104 in Subarachnoid Hemorrhage, FDA Expands Indication for Vizamyl PET Imaging
Published: | Updated:
Neurology News Network. for the week ending June 28, 2025. [WATCH TIME: 4 minutes]
Here's some of what is coming soon to NeurologyLive® this week.
Atogepant Outperforms Topiramate, IND Accepted for ORX142, Prasinezumab Heads to Phase 3 Parkinson Disease Studies
Published: | Updated:
Neurology News Network. for the week ending June 21, 2025. [WATCH TIME: 4 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 20, 2025.
Researchers uncover a latent infection model for Creutzfeldt-Jakob disease, revealing insights into its mysterious origins and potential triggers.
Here's some of what is coming soon to NeurologyLive® this week.
Once-Nightly Oxybate Reduces Sleep-Related Eating, Samelisant Improves Excessive Daytime Sleepiness, Tirzepatide's Impact on OSA and Obesity
Published: | Updated:
Neurology News Network. for the week ending June 14, 2025. [WATCH TIME: 4 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 13, 2025.
Here's some of what is coming soon to NeurologyLive® this week.
RGX-202 Shows Continued Promise in DMD, AJ201 Meets End Points in Spinal and Bulbar Muscular Atrophy, Ponesimod Effect Sustained Over Long-Term
Published: | Updated:
Neurology News Network. for the week ending June 7, 2025. [WATCH TIME: 4 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 6, 2025.
Here's some of what is coming soon to NeurologyLive® this week.
ADDRESS-LC Study of Long COVID Initiated, Phase 4 Trial Testing IVIg Transition to Efgartigimod, Lack of Rebound Effect Seen in Ozanimod
Published: | Updated:
Neurology News Network. for the week ending May 31, 2025. [WATCH TIME: 4 minutes]
Host Jeffrey Wilken, PhD, chats with Riley Bove, MD, about the third day of the 2025 CMSC Annual Meeting in Phoenix, Arizona.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 30, 2025.
AHN Saint Vincent Hospital offers advanced neurological care, reducing wait times and providing local access to specialized treatments for various conditions.
Host Jeffrey Wilken, PhD, chats with Anthony Feinstein, MPhil, PhD, FRCP, about the second day of the 2025 CMSC Annual Meeting in Phoenix, Arizona.
Advertisement
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
2026 Rachel Horne Prize Winner Sandra Vukusic, MD, PhD, on Advancing Women's Health in MS
2
FDA Accepts Fenebrutinib NDA Under Priority Review for Relapsing and Primary Progressive MS
3
Givinostat Data Point to Delayed Loss of Ambulation, Preserved Muscle Tissue in DMD
4
Phase 4 Study Shows Stable Motor Function in Adults With SMA on Risdiplam
5